Akorn (AKRX) Tops Q1 EPS by 10c, Guidance Tops Views, Announces Standstill Agreement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Akorn (AKRX) Tops Q1 EPS by 10c, Guidance Tops Views, Announces Standstill Agreement

Akorn Provides Preliminary First Quarter 2019 Results and Full Year Guidance

May 7, 2019 7:05 AM EDT

-Operational improvements drive sequential growth-

-Full year outlook anticipates further sequential growth throughout the year-

LAKE FOREST, Ill., May 07, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its preliminary financial results for the first quarter of 2019.

First Quarter 2019 and Recent Business Highlights

Net revenue was $166 million, up 8% from the fourth quarter of 2018, down 10% from the prior year quarterNet loss was $82 million, compared to $215 million in the fourth quarter of 2018 and... More